Hybridization of calcium antagonist subclasses like benzothiazepines and phenylalkylamines was an attempt to increase beneficial and/or minimize undesirable side effects. The compound KT-362 (5-[3-[[2-(3,4-dimethoxyphenyl)-ethyl]amino]-1-oxopropyl]-2,3,4,5-tetrahydro-1,5-benzothiazepine fumarate) represents such a hybrid containing structural elements of verapamil as well as of diltiazem (Fig. 1) . Inter alia KT-362 was found to be effective in the suppression of digitalis and adrenaline induced arrhythmia, 3) to reduce ischemia-reperfusion injury in dogs 4) and to exert cardioprotective effects in the stunned canine myocardium. 5) As a result, KT-362 is currently undergoing clinical trials in Japan as an antiarrhytmic agent with additional clinical potential in treating myocardial ischemia and hypertension. 6) Thus it was of interest to investigate the electrophysiological properties of MM 10 (2,3-dihydro-1-[N- [2-(3,4- [1, 4] thiazine fumarate), two newly synthesized substances structurally closely related to KT-362 ( Fig. 1 ) with regard to a possible structure-activity relationship.
MATERIALS AND METHODS
Preparations Guinea pigs of either sex (240-320 g) were killed by a blow on the neck and their hearts were removed rapidly via a midsternal thoracotomy. The left atrium was excised from the heart. Right atrium was further dissected. Only the area containing the sinoatrial node (approximate size of 0.5ϫ0.5 cm) was used for experiments. Papillary muscles were isolated from the right ventricle after removing Purkinje fibers to prevent spontaneous activity. Purkinje fibers were carefully removed from the left ventricle, only spontaneously beating preparations were used for experiments.
Experimental Setup Preparations were mounted in a continuous-flow chamber. Papillary muscles and left atria were continuously stimulated with square wave impulses delivered by an anapulse stimulator and an isolation unit (World Precision Instruments, New Haven, CT, U.S.A.) at a frequency rate of 1 Hz. Membrane potentials and maximum upstroke velocities (V max ) were measured with respect to a grounded bath by using glass microelectrodes of 10-28 MW resistance filled with 3 M KCl and two amplifiers (M 701 and M 707 Microprobe System, World Precision Instruments, New Haven, CT, U.S.A.). Action potentials were recorded with a dual beam storage oscilloscope (Tektronix Inc., Beaverton, OR, U.S.A.). Photos of membrane potentials were taken every five minutes (Nihon Kohden Camera PC-2A, Nihon Kohden, Tokyo, Japan) and signals analyzed after magnification.
Drugs and Solutions During the experiments preparations were perfused with a modified Tyrode's solution containing (in mmol/l) NaCl 136.9, KCl 2.7 (for Purkinje fibers) or 5.4 (for left atria, papillary muscles and sinoatrial nodes), MgCl 2 1.05, NaH 2 PO 4 0.42, CaCl 2 1.8 and glucose 5.0. The solution was continuously bubbled with a mixture of 95% O 2 and 5% CO 2 at a temperature of 37Ϯ1°C.
The investigated compounds MM 10 and MM 11 were synthesized at the Department of Pharmaceutical Chemistry, University of Vienna. 7) Drugs were dissolved in modified Tyrode's solution, stock solutions were prepared freshly every day.
Experimental Protocols After an equilibration period of at least one hour preparations were impaled and action potentials recorded for 30 min in drug-free Tyrode's solution. After this control period drugs were added at increasing concentrations until a steady state was reached followed by a washout period of 60 min. Continuous impalements were maintained throughout each experiment.
Statistics Data are presented as meansϮS.D. and evaluated statistically using Student's t-test for unpaired observations. A p value less than 0.05 was considered to indicate a significant change.
Chemical Syntheses The syntheses of MM 10 and MM 11 is shown in Fig. 2 
1-[[N-[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]-acetyl]-2,3-dihydro-1H-pyrido[2,3-b][1,4]thiazine (3)
To a solution of compound 2 (0.228 g, 1 mmol) in dry ethanol (8 ml) triethylamine (0.111 g, 1.1 mmol) and 2-(3,4-dimethoxyphenyl)-N-methyl-1-ethylamine (0.195 g, 1 mmol) were added. The reaction mixture was refluxed for 3 h. After this the solvent was removed under reduced pressure. The residue was diluted with water and extracted three times with dichloromethane. The combined organic layers were dried over Na 2 SO 4 , filtered, and concentrated to give a crude product, which was purified by chromatography (dichloromethane-methanol, v/vϭ20 : 1) to give an oil. Yield: 0.265 g, 68%.
1 H-NMR ( 
Acryloyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]thiazine (4)
To a solution of compound 1 (0.152 g, 1 mmol) in dry THF (5 ml) triethylamine (0.101 g, 1 mmol) and chloropropionyl chloride (0.317 g, 2.5 mmol) were added. The reaction mix-ture was stirred for 3 h at room temperature. After this the solvent was removed under reduced pressure. The residue was diluted with water and extracted three times with dichloromethane. The combined organic layers were dried over Na 2 SO 4 , filtered, and concentrated to give a crude product, which was purified by chromatography (dichloromethane-methanol, v/vϭ10 : 1) to give an oil. This was recrystallized from dil. ethanol to give 4 as white needles: mp, 137-139°C; yield, 0.130 g, 63%.
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1-[3-[N-[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]-propionyl]-2,3-dihydro-1H-pyrido[2,3-b][1,4]thiazine (5)
To a solution of compound 4 (0.206 g, 1 mmol) in dry ethanol (8 ml) 2-(3,4-dimethoxyphenyl)-N-methyl-1-ethylamine (0.195 g, 1 mmol) was added. The reaction mixture was refluxed for 3 h. After this the solvent was removed under reduced pressure. The residue was diluted with water and extracted three times with dichloromethane. The combined organic layers were dried over Na 2 SO 4 , filtered, and concentrated to give a crude product, which was purified by chromatography (toluene-ethylacetate-triethylamin, v/v ϭ6 : 3 : 1) to give a pale yellow oil. Yield: 0.258 g, 64%. Used in the same concentrations MM 11 did not exert any effect on action potential amplitude, maximum upstroke velocity and membrane resting potential. Action potential duration at 50% time to repolarization was prolonged from 195.0Ϯ9.13 to 210.0Ϯ10.8 ms (3 mmol/l) and to 212.5Ϯ 10.41 ms (30 mmol/l) (nϭ4, pϽ0.05) as well as at 90% time to repolarization from 212.25Ϯ4.79 to 246.25Ϯ14.36 ms (3 mmol/l) and to 262.5Ϯ9.57 ms (30 mmol/l) (nϭ4, pϽ0.05) prolonged in a concentration-dependent manner. All observed effects occurred immediately after drug application reached maximum in approximately 30 min and where completely reversible during washout with drug-free Tyrode's solution. Original recordings are shown in Fig. 2 .
Effects on Action Potential of Left Atria Similar to experiments with papillary muscles action potential duration at 50% time to repolarization was clearly prolonged from 44.75Ϯ5.5 to 51.0Ϯ4.62 ms (3 mmol/l), to 58.0Ϯ5.72 ms (10 mmol/l) and to 66.75Ϯ7.68 ms (30 mmol/l) (nϭ4, pϽ 0.05) as well as at 90% time to repolarization from 97.0 Ϯ2.16 to 113.25Ϯ3.95 ms (3 mmol/l) (nϭ5, pϽ0.05), to 130.0Ϯ4.08 ms (10 mmol/l) and to 147.5Ϯ6.54 ms (30 mmol/l) (nϭ4, pϽ0.05), during exposure to MM 10. On the other hand the compound did not produce any change in APD 20 , membrane resting potential, action potential amplitude or V max .
Similar results could be obtained with MM 11 (3 mmol/l and 30 mmol/l). In these experiments action potential amplitude, V max and membrane resting potential remained unchanged, whereas the investigated substance produced significant prolongation in action potential duration at 50% time to repolarization was prolonged from 42.5Ϯ2.9 to 55.75Ϯ 1.2 ms (3 mmol/l) and to 71.67Ϯ2.89 ms (30 mmol/l) (nϭ4, pϽ0.05) as well as at 90% time to repolarization from 96.25Ϯ9.46 to 123.75Ϯ8.54 ms (3 mmol/l) and to 161.67Ϯ 10.41 ms (30 mmol/l) (nϭ4, pϽ0.05). In contrast to experiments with MM 10 APD 20 was as well prolonged from 21.25Ϯ2.5 to 28.75Ϯ2.5 ms (3 mmol/l) and to 33.33Ϯ2.89 ms (10 mmol/l) (nϭ4, pϽ0.05). Both substances started to exert their effects soon after application, maximum effects could be measured after approximately 30 min and were completely reversible during washout. Exposure to MM 11 led to a concentration-dependent prolongation of action potential duration at 50% time to repolarization from 195.0Ϯ48.22 to 236.67Ϯ55.08 ms (3 mmol/l, nϭ3) and to 263.33Ϯ58.59 ms (30 mmol/l, nϭ3) as well as at 90% time to repolarization from 285.0Ϯ40.93 to 376.67Ϯ64.29 ms (3 mmol/l, nϭ3) and to 406.67Ϯ81.45 ms (30 mmol/l, nϭ3, pϽ0.05). Slope of slow diastolic depolarization and rate of activity were significantly decreased at a concentration of 30 mmol/l from 12.0Ϯ2.0 to 8.0Ϯ2.0 mV/s and (nϭ3, pϽ0.05) and from 44.0Ϯ4.58 to 33.0Ϯ3.0 beats/min (nϭ3, pϽ0.05). In 3 out of 6 experiments MM 11 in a concentration of 30 mmol/l led to the occurrence of early afterdepolarizations with a take-off potential between Ϫ50 and Ϫ60 mV in 4 to 6 min after drug application. Early afterdepolarizations and all other observed effects were completely reversible during washout. Original recordings from action potential and early afterdepolarizations are shown in Fig. 4 . In the same concentration MM 11 exerted similar but more pronounced effects. In these experiments effects as well occurred soon after drug application reached maximum in approximately 30 min and were completely reversible during washout with drug-free physiological salt solution. 
Effects on Action Potential of Sinoatrial Nodes

DISCUSSION
Although the effects of MM 11 were more pronounced both compounds exerted very similar electrophysiological profiles. Since phase 0 of action potential of papillary muscles, left atria and Purkinje fibers is generated by fast influx of sodium ions, action potential amplitude and V max are good indicators of fast inward current I Na . 8) This current seems not to be affected by the investigated substances considering the fact that neither MM 10 nor MM 11 produced any change in APA or V max of these preparations. While the action potential duration is maintained by a balance between influx of calcium ions (I si ) during the plateau phase and the activation of several repolarizing outward potassium currents like I K and/or I K1 . 9, 10) So prolongation of action potential duration as it was caused by MM 10 and MM 11 in papillary muscles and left atria as well as in Purkinje fibers may be due to either an increase in I si or a decrease in outward current. The first possibility is rather unlikely for both compounds exerted negative inotropic effects in isolated guinea pig papillary muscles.
11) Depression of potassium currents and concomitant prolongation of action potential duration at 90% time to repolarization may as well provide an explanation for the decrease in rate of activity that could be observed in experiments with Purkinje fibers. Additionally, MM 11 was found to depress slope of slow diastolic depolarization in these preparations, probably due to a decrease in pacemaker current.
The fact that action potential duration at 20% and 50% time to repolarization was shortened or not affected by MM 10 and MM 11 can be attributed to a decrease in I si in part overlapped by the simultaneous delay in repolarization. This assumption is supported by the results obtained in experiments with sinoatrial nodes. In this preparation phase 0 and phase 1 of transmembrane action potential are mainly dependent on depolarizing slow inward calcium current whereas activation of fast sodium channels does not seem to play any role. 12, 13) Application of MM 10 and MM 11 led to significant decreases in action potential amplitude and V max as well as in slope of slow diastolic depolarization and rate of activity, as it is expected for calcium channel antagonists.
Though experimental data from these experiments do not provide direct evidence concerning the influence of MM 10 and MM 11 on depolarizing and/or repolarizing currents, following conclusions may be reasonable: (i) fast sodium current seems not to be affected, (ii) I si is decreased as well as (iii) one or more repolarizing potassium currents. According to the model of January and Riddle 14, 15) the delay in repolarization caused by MM 11 may provide for the "conditioning phase" preceeding the activation of a depolarizing inward current and finally leading to the occurrence of early afterdepolarizations.
In contrast to its derivatives KT-362 led to a concentrationdependent reduction in action potential amplitude and V max in guinea pig ventricular muscle. 16) In isolated guinea pig hearts KT-362 produced a concentration-dependent decrease in atrial rate with an EC 50 of 20 mmol/l. 17) In addition to an inhibition of the L-type calcium current Yuan-Na and coworkers 18) found a decrease in peak sodium current in guinea pig ventricular myocytes in a concentration range from 10 to 30 mmol/l. In the same study KT-362 inhibited the delayed rectifier potassium current and the inward rectifier potassium current. The compound is as well considered to act in a ryanodine-like manner as an inhibitor of intracellular calcium release. 19, 20) Concerning the structure-activity relationship the results of this study gave rise to the assumption, that the replacement of the benzothiazepine nucleus by a pyridothiazine ringsystem leads to a weakening or even a loss of sodium channel blocking ability whereas calcium antagonistic characteristics as well as depressing effects on potassium currents are preserved. Shortening of the side chain may account for the fact that the effects exerted by MM 11, particu- larly those on repolarization, were more pronounced than that performed by MM 10. Whether the investigated 1,4-pyridothiazines in accordance with the mother compound KT-362 act on intracellular calcium stores and which ion currents they affect in particular is left to further investigations.
